Knappertz Volker 4
4 · Aurinia Pharmaceuticals Inc. · Filed Feb 29, 2024
Insider Transaction Report
Form 4
Knappertz Volker
EVP, Research and Development
Transactions
- Sale
Common Stock
2024-02-27$6.10/sh−4,930$30,073→ 319,128 total
4 · Aurinia Pharmaceuticals Inc. · Filed Feb 29, 2024
Common Stock